SXC-MedfusionRx acquisition officially closed
LISLE, Ill. — SXC Health Solutions announced Wednesday that it had completed its acquisition of independent specialty pharmacy provider MedfusionRx in a deal worth $100 million in cash, with an additional $5.5 million subject to the achievement of certain performance targets in fiscal year 2012.
The waiting period under the Hart-Scott-Rodino Act expired Dec. 24.
"We are very pleased to welcome MedfusionRx’s employees and customers into the SXC fold," said SXC president and CEO Mark Thierer. "This acquisition will help transform our specialty pharmacy business by expanding our presence and enhancing our capabilities in this rapidly growing segment of the PBM industry. We are excited with the growth prospects of this acquisition and look forward to capitalizing on our revenue and cost-saving synergy opportunities."
MedfusionRx specializes in bleeding disorders, growth hormone deficiency, multiple sclerosis, rheumatoid arthritis, plaque psoriasis, Crohn’s disease and hepatitis C, as well as medications for patients with cancer and in the preventive treatment of RSV. The company operates a satellite pharmacy in Alabama and six additional pharmacies in Tennessee, Mississippi, West Virginia, Texas, Louisiana and Kansas.
Report: More than a quarter of U.S. kids take at least one chronic med
NEW YORK — More than 25% of children and teens take at least one medication on a daily basis, and nearly 7% are on two or more drugs, the Wall Street Journal reported Tuesday, citing 2009 data from Medco Health Solutions. Drawing additional data from IMS Health, the article noted that prescriptions for hypertension in people under the age of 20 years could reach 5.5 million for 2010 by the time year-end results are tabulated, which would mark a rise of 17% since 2007.
The rise in prescription drug use among children has been attributed to increasing awareness among physicians and parents of available therapeutic options for kids and teens, earlier screening and diagnosis of chronic disease, and a rise in unhealthy eating and exercise habits among kids. That has many healthcare professionals concerned. While much is known about the effects of drugs to treat such conditions as asthma and attention-deficit hyperactivity disorder, much less is known about the long-term effects of many other chronic care drugs on children — these drugs have been tested on adults, not kids, many experts have warned.
Bartell donates flu vaccines to help community outreach programs through local schools of pharmacy
SEATTLE — In an effort to help people in local underserved communities and students in need stay well this flu season, Bartell Drugs will give 4,000 flu vaccines to the University of Washington and Washington State University for use in pharmacy programs at both universities. Each school will receive 2,000 doses of the current flu vaccines to support local student pharmacy outreach programs.
"We’re proud to give the donations to both schools in support of their missions of teaching and community service," said Bartell Drugs chairman and CEO George Bartell. "We’ve been an advocate of the programs at both schools for many years. This is a way for us to show our support for their ongoing outreach efforts to the communities they serve.”
UW’s School of Pharmacy will use the donated vaccines to benefit several local tribal communities and safety-net nonprofit organizations, including Aloha House, the Salvation Army and area drug treatment centers.
WSU’s College of Pharmacy will use its vaccines to boost immunization rates among college students in Pullman and Spokane — a group that is known to be traditionally under-vaccinated and particularly vulnerable to influenza infection due to high-density living conditions, which help foster the spread of the illness.